Fresenius Must Sell Clinics To Finish $2B Liberty Buy: FTC

Law360, New York (February 28, 2012, 8:07 PM EST) -- The Federal Trade Commission will require Fresenius Medical Care AG & Co. to sell 60 outpatient dialysis clinics to resolve the FTC's claims that the company's proposed $2.1 billion acquisition of Liberty Dialysis Holdings Inc. would be anti-competitive, the agency said Tuesday.

Fresenius will have to divest clinics in 43 local markets in order to gain regulatory approval for the deal under a proposed consent order, the FTC said.

The company proposed to acquire Liberty for about $2.1 billion under an agreement dated Aug. 1, according...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.